Skip to content

Stablecoin Development Corp

SDEV

CIK 0001389545 · Pharmaceutical Preparations · NYSE

  • NovaBay Pharmaceuticals, Inc. (until 2026-03-23)
← back to feed
Revenue (TTM)
$310K
−88.6% YoY Q1 May 2026
Net Income (TTM)
$556.86M
−8,632.9% YoY Q1 May 2026
EPS Diluted (TTM)
$9.86
+35.4% YoY Q1 May 2026
Gross Margin
1,105.8%
Q1 May 2026
Operating Margin
5,113.5%
Q1 May 2026
Net Margin
179,631.6%
Q1 May 2026
Free Cash Flow (TTM)
−$6.33M
Q1 May 2026
Cash
$18.41M
Q1 May 2026
Total Debt
$106K
Q1 May 2026
Shares Outstanding
27.12M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings